CELH
Overvalued by 45.1% based on the discounted cash flow analysis.
Market cap | $9.76 Billion |
---|---|
Enterprise Value | $8.84 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.62 |
Beta | 1.63 |
Outstanding Shares | 235,191,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 79.77 |
---|---|
PEG | -185.89 |
Price to Sales | 8.02 |
Price to Book Ratio | 8.02 |
Enterprise Value to Revenue | 6.65 |
Enterprise Value to EBIT | 72.28 |
Enterprise Value to Net Income | 76 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.13 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...